Rady Children’s oncologist Paula Aristizabal receives $4M to diversify clinical trials participation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Paula Aristizabal, a pediatric oncologist at Rady Children’s Hospital-San Diego and associate professor of pediatrics in pediatric hematology/oncology at the University of California San Diego and Moores Cancer Center, received a $4 million R01 research grant to expand a pilot program aimed at improving diverse participation in pediatric cancer clinical trials.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Data from the phase III ASCENT-03 study demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival for Trodelvy (sacituzumab govitecan-hziy) compared to chemotherapy as first-line treatment in patients with metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitors. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login